Cetuximab, capecitabine, and oxaliplatin (Cet-CapOx) with concurrent radiotherapy (RT) in advanced rectal cancer (RC): Results of a phase I/II trial

被引：0
|
作者：
Arnold, D.
Hipp, M.
Liersch, T.
Dellas, K.
Koelbl, O.
Hohenberger, W.
Lordick, F.
Suelberg, H.
Sauer, R.
Roedel, C.
机构：
[1] Martin Luther Univ Halle Wittenberg, Halle, Germany
[2] Univ Hosp, Regensburg, Germany
[3] George August Univ, Gottingen, Germany
[4] Friedrich Alexander Univ, Erlangen, Germany
[5] Tech Univ, Munich, Germany
[6] WiSP Inst, Langenfeld, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4042
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cetuximab in combination with capecitabine, oxaliplatin and concomitant radiotherapy (CET-CAPOX-RT) as preoperative therapy for rectal cancer
    Roedel, C.
    Hipp, M.
    Arnold, D.
    Reese, T.
    Lordick, F.
    Sauer, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 20 - 20
  • [2] Phase I/II study of cetuximab, capecitabine and oxaliplatin (CAPOX) combined with standard radiotherapy (RTX) as neoadjuvant treatment of advanced rectal cancer (RC).
    Arnold, D.
    Hipp, M.
    Reese, T.
    Hohenberger, W.
    Liersch, T.
    Lordick, F.
    Suelberg, H.
    Sauer, R.
    Roedel, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 164S - 164S
  • [3] Cetuximab in combination with capecitabine, oxaliplatin and concomitant radiotherapy (CET-CAPOX-RT) as preoperative therapy for rectal cancer
    Roedel, C.
    Arnold, D.
    Hipp, M.
    Sauer, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S82 - S83
  • [4] Neoadjuvant cetuximab, capecitabine, and radiotherapy (RT) in locally advanced resectable rectal cancer: results of a phase II trial
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative triple treatment for rectal cancer (CET-CAPOX-RT-Phase-I/II Study): Influence on long-term survival and relevance of biomarkers
    Liersch, Torsten
    Conradi, Lena-Christin
    Sprenger, Thilo
    Middel, Peter
    Suelberg, Heiko
    Roedel, Franz
    Rueschoff, Josef
    Beissbarth, Tim
    Arnold, Dirk
    Roedel, Claus
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer
    Roedel, Claus
    Arnold, Dirk
    Hipp, Matthias
    Liersch, Torsten
    Dellas, Kathrin
    Iesalnieks, Igors
    Hermann, Robert Michael
    Lordick, Florian
    Hinke, Axel
    Hohenberger, Werner
    Sauer, Rolf
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (04): : 1081 - 1086
  • [7] Phase II XERT trial: Neoadjuvant cetuximab, capecitabine and radiotherapy (RT) in locally advanced resectable rectal cancer
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    EJC SUPPLEMENTS, 2009, 7 (02): : 327 - 327
  • [8] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Hasegawa, J.
    Kato, T.
    Nishimura, J.
    Yoshioka, S.
    Noura, S.
    Kagawa, Y.
    Yasui, M.
    Ikenaga, M.
    Murata, K.
    Hata, T.
    Matsuda, C.
    Mizushima, T.
    Yamamoto, H.
    Doki, Y.
    Mori, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Nishimura, Junichi
    Hasegawa, Junichi
    Kato, Takeshi
    Yoshioka, Shinichi
    Noura, Shingo
    Kagawa, Yoshinori
    Yasui, Masayoshi
    Ikenaga, Masakazu
    Murata, Kohei
    Hata, Taishi
    Matsuda, Chu
    Mizushima, Tsunekazu
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Mori, Masaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (04) : 707 - 716
  • [10] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Junichi Nishimura
    Junichi Hasegawa
    Takeshi Kato
    Shinichi Yoshioka
    Shingo Noura
    Yoshinori Kagawa
    Masayoshi Yasui
    Masakazu Ikenaga
    Kohei Murata
    Taishi Hata
    Chu Matsuda
    Tsunekazu Mizushima
    Hirofumi Yamamoto
    Yuichiro Doki
    Masaki Mori
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 707 - 716
12345